BANNEN LYNNE CANNE has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are EMELEN KRISTOF VAN, NEUROGEN CORP BRANFORD and ONCODESIGN SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Environmental technology | |
#6 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Bannen Lynne Canne | 13 |
#2 | Nuss John M | 11 |
#3 | Khoury Richard George | 10 |
#4 | Parks Jason Jevious | 10 |
#5 | Mac Morrison B | 9 |
#6 | Jammalamadaka Vasu | 9 |
#7 | Chan Diva Sze-Ming | 9 |
#8 | Wang Yong | 9 |
#9 | Xu Wei | 8 |
#10 | Leahy James William | 8 |
Publication | Filing date | Title |
---|---|---|
US2012070368A1 | Methods of Using C-Met Modulators | |
WO2007024744A2 | Heterocyclic carboxamide compounds as steroid nuclear receptor ligands | |
WO2004050681A2 | Kinase modulators |